Pliant Therapeutics, Inc.
COMPOSITIONS AND METHODS FOR ACTIVATION OF INTEGRINS
Last updated:
Abstract:
Disclosed herein are pharmaceutical agents and compositions that activate integrin heterodimers that contain beta-1 integrin protein that specifically bind laminin protein. Such agents and compositions are useful for treating diseases related to muscle malfunction, including muscular dystrophies.
Status:
Application
Type:
Utility
Filling date:
13 Nov 2020
Issue date:
20 May 2021